Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00368
|
|||||
| Drug Name |
Brigatinib
|
|||||
| Synonyms |
Alunbrig
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C29H39ClN7O2P
|
|||||
| Canonical SMILES |
CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC
|
|||||
| InChI |
InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)
|
|||||
| InChIKey |
AILRADAXUVEEIR-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 1197953-54-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 584.1 | Topological Polar Surface Area | 85.9 | ||
| Heavy Atom Count | 40 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 9 | |||
| XLogP |
4.6
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ABCB5 | Transporter Info | ATP-binding cassette sub-family B member 5 | Substrate | [1] | |
| BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [1] | ||
| References | ||||||
| 1 | NDA/BLA Multidisciplinary Review and Evaluation of ALUNBRIG (brigatinib) From FDA. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.